1 - The NIDDK Clearinghouse - National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
2 - National Association for Continence - Harris Interactive Study - June 2004.

What the Kit does:

Developed especially for primary care physicians, the BladderScan^® Bladder Assessment Kit is a comprehensive program to bring urology into your practice. The kit provides the essential assessment capabilities you need to diagnose, prescribe for, and treat your patients' bladder and urinary problems. The instruments in the kit allow for rapid and noninvasive measurement of urinary flow and residual bladder volume (PVR, or post void residual).

Indications

If your patients present any of the following indications, a BladderScan® Bladder Assessment Kit may be good medicine for your practice:
	BPH
	Over Active Bladder
	Diabetic/ Neurogenic Bladder
	Acute Urinary Retention
	Urinary Incontinence
	MS/ Parkinson/ Self-care
	Bladder Outlet Obstruction
The kit allows you to quickly and easily take key diagnostic steps before prescribing medication for bladder dysfunction or writing a referral to a urologist.

Benefits for you, your patients, and your practice:

You receive immediate and accurate information to diagnose bladder dysfunction. Because the tests can be conducted quickly, you can discuss potential treatment options with your patients at the time of their office visit. Your patients can avoid possible time-consuming referrals, pain from catheterization and the related risk of infection.

Kit Contents:
	A BladderScan® Volume Measurement Instrument - your choice of either a BVI 6400 handheld model with ScanPoint® online imaging services, OR a BVI 9400 table-top model with integrated printer
	A FloPoint® Elite Uroflow System
	AUA Symptom Index for BPH and UDI-6 Incontinence Questionnaires to assist in patient communication
	The Urology for Primary Care Manual & MedReviews on Optimal Bladder Strategies for Primary Care
	Additional services - such as clinical training, CEU, reimbursement questions consultations etc.

Reimbursement:

The BladderScan^® and FloPoint^® tests can easily be conducted in only a few minutes. The CPT Codes (51741 and 51798) are approved for reimbursement by Medicare. Both uroflowmetry and post void residual (PVR) are covered.

Clinical:

Herbert Lepor, MD (Department of Urology, New York University, School of Medicine, New York, NY), recommends steps for the evaluation of patients with benign prostatic hyperplasia (BPH), a condition that has been estimated to affect 50% of men aged 51-60 years and 90% of men older than 80 years in the United States. Christopher E. Kelly, MD (Department of Urology, New York University, School of Medicine, New York, NY), concludes that "When evaluating patients with voiding dysfunction, noninvasive tests such as uroflowmetry and measurement of post void residual (PVR) can help to determine whether additional testing is needed."

Click here to see a bibliography of additional clinical studies.

The new BladderScan^® Bladder Assessment Kit can help you evaluate and treat your patients' bladder and urinary problems.

Please contact your Verathon Medical® representative for a BladderScan^® Bladder Assessment Kit demonstration, or visit us at one of our upcoming trade shows.